Global Bioenergies Management
Management criteria checks 4/4
Global Bioenergies' CEO is Marc Delcourt, appointed in Feb 2009, has a tenure of 15.83 years. total yearly compensation is €80.74K, comprised of 41.3% salary and 58.7% bonuses, including company stock and options. directly owns 2.58% of the company’s shares, worth €387.65K. The average tenure of the management team and the board of directors is 6.2 years and 5.2 years respectively.
Key information
Marc Delcourt
Chief executive officer
€80.7k
Total compensation
CEO salary percentage | 41.3% |
CEO tenure | 15.8yrs |
CEO ownership | 2.6% |
Management average tenure | 6.2yrs |
Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Global Bioenergies SA's (EPA:ALGBE) Intrinsic Value Is Potentially 60% Above Its Share Price
Sep 18Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?
Jun 21Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?
Jun 28Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?
Oct 11Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?
Oct 25Global Bioenergies (EPA:ALGBE) Shareholders Have Enjoyed An Impressive 187% Share Price Gain
Mar 20CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -€7m |
Mar 31 2024 | n/a | n/a | -€8m |
Dec 31 2023 | €81k | €33k | -€9m |
Sep 30 2023 | n/a | n/a | -€9m |
Jun 30 2023 | n/a | n/a | -€10m |
Mar 31 2023 | n/a | n/a | -€11m |
Dec 31 2022 | €223k | €145k | -€12m |
Sep 30 2022 | n/a | n/a | -€11m |
Jun 30 2022 | n/a | n/a | -€10m |
Mar 31 2022 | n/a | n/a | -€11m |
Dec 31 2021 | €288k | €135k | -€12m |
Sep 30 2021 | n/a | n/a | -€12m |
Jun 30 2021 | n/a | n/a | -€12m |
Mar 31 2021 | n/a | n/a | -€11m |
Dec 31 2020 | €242k | €125k | -€11m |
Sep 30 2020 | n/a | n/a | -€13m |
Jun 30 2020 | n/a | n/a | -€12m |
Mar 31 2020 | n/a | n/a | -€12m |
Dec 31 2019 | €194k | €125k | -€14m |
Sep 30 2019 | n/a | n/a | -€13m |
Jun 30 2019 | n/a | n/a | -€12m |
Mar 31 2019 | n/a | n/a | -€13m |
Dec 31 2018 | €155k | €155k | -€14m |
Sep 30 2018 | n/a | n/a | -€16m |
Jun 30 2018 | n/a | n/a | -€17m |
Mar 31 2018 | n/a | n/a | -€16m |
Dec 31 2017 | €170k | €135k | -€14m |
Compensation vs Market: Marc's total compensation ($USD84.24K) is below average for companies of similar size in the French market ($USD317.72K).
Compensation vs Earnings: Marc's compensation has been consistent with company performance over the past year.
CEO
Marc Delcourt (52 yo)
15.8yrs
Tenure
€80,738
Compensation
Mr. Marc Delcourt is a Co-Founder of Global Bioenergies and serves as its Chief Executive Officer since February 13, 2009. Mr. Delcourt was the Founder of Biomethodes SA and served as its Chairman, Preside...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.8yrs | €80.74k | 2.58% € 387.6k | |
Co-Founder & President of Scientific Advisory Board | no data | no data | no data | |
Administrative & Financial Director and CFO | 7.2yrs | no data | no data | |
Technical Director | 5.3yrs | no data | no data | |
Vice President of Investor Relations | 10.9yrs | no data | no data | |
Legal Director | 4.3yrs | no data | no data | |
Chief Business Officer | 1.2yrs | no data | no data |
6.2yrs
Average Tenure
Experienced Management: ALGBE's management team is seasoned and experienced (6.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.8yrs | €80.74k | 2.58% € 387.6k | |
Co-Founder & President of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 5.7yrs | €3.25k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 3.3yrs | €4.83k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | no data | €4.28k | no data | |
Independent Chairman | 4.8yrs | €12.50k | no data |
5.2yrs
Average Tenure
66.5yo
Average Age
Experienced Board: ALGBE's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 04:20 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Global Bioenergies SA is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Markus Mayer | Baader Helvea Equity Research |
Mark Cartlich | Edison Investment Research |
Stephanie Lefebvre | Gilbert Dupont |